PEREZ NYSSEN, O., Á. PÉREZ AÍSA, D. VAIRA, G. FIORINI, L. RODRIGO, A. KECO HUERGA, M. CASTRO FERNÁNDEZ, J. KUPCINSKAS, L. JONAITIS, B. TEPEŠ, L. VOLOGZHANINA, M. CALDAS ÁLVAREZ, S. MARTINEZ DOMINGUEZ, E. ALFARO, A. LUCENDO, L. BUJANDA FERNÁNDEZ DE PIÉROLA, T. DI MAIRA, J. BARRIO, Huguet J.M., J. PEREZ LASALA, A. SILKANOVNA SARSENBAEVA, D. BORDIN, M. LEJA, A. GASBARRINI, S. GEORGOPOULOS, F. LERANG, P. PHULL, T. ROKKAS, Y. SHVETS, D. LAMARQUE, F. HELUWAERT, A. TONKIC, M. VENERITO, I. SIMSEK, V. MILIVOJEVIĆ, Buzás G.M., V. LAMY, W. MARLICZ, L. BOYANOVA, P. BYTZER, L. CAPELLE, Lumír KUNOVSKÝ, A. GOLDIS, C. BEGLINGER, M. ESPADA, I. PUIG, F. MÉGRAUD, C. O MORAIN and Gisbert J.P. Empirical second-line treatments in europe: Results from the european registry on H. pylori management (HP-EUREG). In UEG Week 2021. 2021.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Empirical second-line treatments in europe: Results from the european registry on H. pylori management (HP-EUREG)
Authors PEREZ NYSSEN, O., Á. PÉREZ AÍSA, D. VAIRA, G. FIORINI, L. RODRIGO, A. KECO HUERGA, M. CASTRO FERNÁNDEZ, J. KUPCINSKAS, L. JONAITIS, B. TEPEŠ, L. VOLOGZHANINA, M. CALDAS ÁLVAREZ, S. MARTINEZ DOMINGUEZ, E. ALFARO, A. LUCENDO, L. BUJANDA FERNÁNDEZ DE PIÉROLA, T. DI MAIRA, J. BARRIO, Huguet J.M., J. PEREZ LASALA, A. SILKANOVNA SARSENBAEVA, D. BORDIN, M. LEJA, A. GASBARRINI, S. GEORGOPOULOS, F. LERANG, P. PHULL, T. ROKKAS, Y. SHVETS, D. LAMARQUE, F. HELUWAERT, A. TONKIC, M. VENERITO, I. SIMSEK, V. MILIVOJEVIĆ, Buzás G.M., V. LAMY, W. MARLICZ, L. BOYANOVA, P. BYTZER, L. CAPELLE, Lumír KUNOVSKÝ, A. GOLDIS, C. BEGLINGER, M. ESPADA, I. PUIG, F. MÉGRAUD, C. O MORAIN and Gisbert J.P.
Edition UEG Week 2021, 2021.
Other information
Type of outcome Conference abstract
Confidentiality degree is not subject to a state or trade secret
Changed by Changed by: MUDr. Petr Litzman, učo 410621. Changed: 9/10/2021 21:19.
PrintDisplayed: 25/8/2024 09:40